CN101940677A - Traditional Chinese medicinal powder for treating uarthritis - Google Patents

Traditional Chinese medicinal powder for treating uarthritis Download PDF

Info

Publication number
CN101940677A
CN101940677A CN2010102622805A CN201010262280A CN101940677A CN 101940677 A CN101940677 A CN 101940677A CN 2010102622805 A CN2010102622805 A CN 2010102622805A CN 201010262280 A CN201010262280 A CN 201010262280A CN 101940677 A CN101940677 A CN 101940677A
Authority
CN
China
Prior art keywords
rhizoma
radix
powder
medicaments
uarthritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010102622805A
Other languages
Chinese (zh)
Inventor
潘真麟
肖富洲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010102622805A priority Critical patent/CN101940677A/en
Publication of CN101940677A publication Critical patent/CN101940677A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses traditional Chinese medicinal powder for treating uarthritis, belonging to the medicinal preparation products. The powder consists of main medicaments and auxiliary medicaments, wherein the medicaments are golden cypress, rhizoma atractylodis and rhizoma arisaematis, and the auxiliary medicaments are cassia twig, clematis root, safflower, notopterygium root, stephania tetrandra, angelica root, peach kernel, gentian, szechuan lovage rhizome and medicated leaven; the mass ratio of the medicaments is golden cypress 40: rhizoma atractylodis 40: rhizoma arisaematis40: cassia twig 5: clematis root 5: safflower 5: notopterygium root 5: stephania tetrandra 10: angelica root 10: peach kernel 10: gentian 20: szechuan lovage rhizome 20: medicated leaven 20. The powder is prepared by mixing the medicaments in the formula ratio and grinding the medicaments into powder. The traditional Chinese medicinal powder for treating the uarthritis is a specific medicine for the uarthritis, and is suitable for uarthritis patients caused by high trioxypurine.

Description

A kind of Chinese powder medicine for the treatment of gout
Technical field
The present invention relates to medicine, relate to the medicine for the treatment of gout furthermore.
Background technology
Gout is a kind of chronic metabolic disturbance diseases, and its main feature is that urate generates too much or the minimizing of renal excretion uric acid in the body, thereby causes that urate concentration raises in the blood, is called high hematuria acid disease clinically.Uric acid is the dead end product of purine metabolism, and purine is produced by human body cell catabolism.Will refer in particular at tissue after blood uric acid is elevated to a certain degree, deposition and cause arthritic outbreak repeatedly in toe, wrist, ankle, knee joint and the kidney.Severe patient can cause joint movement disorder or deformity, is called gouty arthritis clinically.The normal value of human body uric acid is 150~420umol/L, too much uric acid can form uric acid renal calculus and the infringement of excess of the kidney matter in kidney deposition back, be called urate nephropathy clinically, be gouty nephropathy again, can cause renal colic outbreak, hematuria, hydronephrosis and renal function injury, renal failure and uremia can take place in severe patient, are to cause one of gout patient main causes of death.
The conventional medicament that patient with gout is often taken has aspirin, and indometacin, diclofenac etc., these medicines all exist patient's GI irritation and the big defective of damage.
People have developed many medicines in the process of struggling with gout, the Chinese patent application part of up to a hundred medicines has been arranged.These medicines respectively have its characteristics and curative effect, but people are also in the novel drugs that continues research and development more remarkable treatment effect, side effect is littler, the scope of application is wider treatment gout.
Summary of the invention
The object of the present invention is to provide a kind of Chinese powder medicine for the treatment of gout, make patient with gout can reduce the amount of uric acid in the body rapidly, reach the purpose of curing diabetes.
The Chinese powder medicine of the treatment gout that the inventor provides is made up of principal agent and accessory drugs, and wherein the medical material of principal agent is Cortex Phellodendri, Rhizoma Atractylodis, Rhizoma Arisaematis; The medical material of accessory drugs is Ramulus Cinnamomi, Radix Clematidis, Flos Carthami, Rhizoma Et Radix Notopterygii, Radix Stephaniae Tetrandrae, the Radix Angelicae Dahuricae, Semen Persicae, Radix Gentianae, Rhizoma Chuanxiong, Massa Medicata Fermentata preparata; The quality proportioning of various medical materials is: Cortex Phellodendri 40: Rhizoma Atractylodis 40: Rhizoma Arisaematis 40: Ramulus Cinnamomi 5: Radix Clematidis 5: Flos Carthami 5: Rhizoma Et Radix Notopterygii 5: Radix Stephaniae Tetrandrae 10: the Radix Angelicae Dahuricae 10: Semen Persicae 10: Radix Gentianae 20: Rhizoma Chuanxiong 20: Massa Medicata Fermentata preparata 20.
Cortex Phellodendri in the above-mentioned medical material will be with using after the wine parch; Rhizoma Arisaematis then will be with using after the Rhizoma Zingiberis Recens parch.
The above-mentioned principal agent medical material that is absolutely necessary, accessory drugs are then selected to add according to conditions of patients.
In the above-mentioned principal agent, Cortex Phellodendri is rosaceous plant Cortex Phellodendri (Phellodendron amurense), and bitter in the mouth is cold in nature, and the effect (seeing 2031~2036 pages of the new medical college volumes in Jiangsu " Chinese medicine voluminous dictionary ") of heat clearing and damp drying, eliminating fire and detoxication is arranged; Rhizoma Atractylodis are feverfew RHIZOMA ATRACTYLODIS IANCEAE (Atractylodes lancea) or Atractylis chinensis (Atractylodes chinensis) rhizome, and are warm in nature, and the acrid in the mouth hardship has spleen invigorating, dampness, resolving depression, wards off dirty effect (seeing " Chinese medicine voluminous dictionary " 1066-1069 page or leaf); Rhizoma Arisaematis is the tuber of aroid Rhizoma Arisaematis (Arisaema consanguineum), and the acrid in the mouth hardship is warm in nature, poisonous, energy drying dampness to eliminate phlegm, expelling wind for relieving convulsion, the wet knot of detumescence (seeing " Chinese medicine voluminous dictionary " 329-333 page or leaf).
In the above-mentioned accessory drugs, Ramulus Cinnamomi is the twig of canella Cortex Cinnamomi (Cinnamomum cassia), and acrid-sweet flavor is warm in nature, energy diaphoresis expelling pathogenic factors from muscles, warming the meridian and promoting blood circulation (" Chinese medicine voluminous dictionary " 1771-1773 page or leaf); Radix Clematidis is the root of ranunculaceae plant Radix Clematidis (Clematis chinensis), and acrid in the mouth is salty, and is warm in nature, poisonous, energy wind-damp dispelling, the meridian dredging, expectorant saliva, the hypochondriac lump (" Chinese medicine voluminous dictionary " 1632-1635 page or leaf) of loosing; Flos Carthami is the top and the stigma of irides Stigma Croci (Crocus sativus) style, sweet in the mouth, and property is flat, energy blood circulation promoting and blood stasis dispelling, dispersing stagnation and relieving accumulation of pathogens (" Chinese medicine voluminous dictionary " 2671-2672 page or leaf); Rhizoma Et Radix Notopterygii is umbrella section plant Rhizoma Et Radix Notopterygii (Notopterygium incisum) rhizome, and the acrid in the mouth hardship is warm in nature, the exterior cold of loosing, wind-damp dispelling, sharp joint (" Chinese medicine voluminous dictionary " 1172-1174 page or leaf); Radix Stephaniae Tetrandrae is the root of menispermaceous plants Radix stephaniae tetrandrae (Stephaniatetrandra), and bitter in the mouth is cold in nature, can manage it water, rush down damp-heat in lower-JIAO (seeing " Chinese medicine voluminous dictionary " 981-985); The Radix Angelicae Dahuricae, be the root of the umbrella section plant Xingan Radix Angelicae Dahuricae (Angelica dahurica), angelica anomala (Angelica anomala), Radix angelicae dahuricae (Angelica formosana), acrid in the mouth, warm in nature, can dispel the wind, dampness, the detumescence, pain relieving (seeing " Chinese medicine voluminous dictionary " 675-679); Semen Persicae, be the seed of rosaceous plant peach (Prunus persica), bitter in the mouth, property is flat, can wind-damp dispelling, heat clearing away, parasite killing (seeing " Chinese medicine voluminous dictionary " 1787-1789); Radix Gentianae is the root and rhizome of gentianaceae plant Radix Gentianae (Gentianascabra), and bitter in the mouth is cold in nature, can eliminating pathogen in the liver the gallbladder excess-fire, remove damp-heat in lower-JIAO (seeing " Chinese medicine voluminous dictionary " 627-629); Rhizoma Chuanxiong; Be umbrella section plant Rhizoma Chuanxiong (Ligusticum chuanxiong) rhizome, acrid in the mouth, warm in nature, can new air to open strongly fragrant, dispeiling pathogenic wind and removing dampness, promoting blood circulation and stopping pain (seeing " Chinese medicine voluminous dictionary " P220); Massa Medicata Fermentata preparata is promptly fried to xanchromatic medicine (seeing " Chinese medicine voluminous dictionary " P1740) in the heat pot with Massa Medicata Fermentata.
The Chinese powder medicine of treatment gout of the present invention is that above-mentioned medical material is mixed according to formula proportion, and common the grinding becomes powder, just makes patent medicine.
The Chinese powder medicine using method of treatment gout is oral, every day 3 times, and each 3~6g, 3 days is a course of treatment, uses warm water delivery service; Simultaneously must add the clothes vitamin C, every day 2 times, each 2.The each dose of the person of being in a bad way more greatly.For common patient with gout, can fully recover general 3 courses of treatment.
Chinese powder medicine of the present invention clinical practice, once treated 1000 surplus case, effective percentage reaches more than 95%.Below be the case of some treatments:
Case one: patient Wang Xinming, the former Pingba worker of chemical fertilizer factory suffered from gout 10 years, morbidity in 2007, the trick redness and swelling of joints, pain unbearably, uric acid reaches 487 μ mol/L, is taking powder of the present invention after 3 courses of treatment, the ailing disappearance, uric acid greatly reduces.So far not recurrence.
Case two: patient Chen Fengcai, the man, 66 years old, the two positive workmans of machinery plant in Anshun, because of suffering from gout, double-legged thumb grows " tophus ", and uric acid is up to 620 μ mol/L, and suffers from hypertension, endures ailing the torment to the fullest extent.Taking powder of the present invention after January, there is the mediation sense on the whole body, and uric acid is reduced to 392 μ mol/L, and the gout calculus is dissolved, the ailing disappearance, and other complication has not been sent out yet.
Case three: patient Li Qiang, man, life in 1967, the Anshun Xixiu District bailiff of law court.Suffering from gout 12 years, shows effect repeatedly in the ventilation joint, shows effect once the unusual enlargement of right crus of diaphragm thumb in average two months.The carbamide index is up to 580 μ mol/L, taking powder of the present invention after 3 courses of treatment, the ailing disappearance, and uric acid greatly reduces, state of an illness recovery from illness.So far not recurrence.
Case four: patient Zhao Yongjiu, the Pekinese, the man, 48 years old, suffered from gout 12 years, the unusual enlargement of right crus of diaphragm thumb, pain unbearably, the carbamide index is 538 μ mol/L, exceeds ordinary person's standard.Take powder of the present invention after 1 course of treatment, ailingly just disappear recurrence so far.
Case five: patient Xiao, man, 65 years old, the manager of Anshun pharmaceuticals, phone 13885355505 was suffered from gout more than 20 year, and finger, toe have the gout calculus entirely, all occur swelling, pain on every side, the uric acid index often is 650~700 μ mol/L, is in a bad way, even causes that renal function goes down.See the doctor for treatment for many years all to no effect, idol has alleviation, as long as just recurrence of drug withdrawal again and again, is difficult to be completely cured.Take 3 courses of treatment of powder of the present invention, uric acid is reduced to normal level, and pain disappears, and need not continue to take medicine, and has returned to one's perfect health.
Case six: certain patient, the man, 45 years old, the Anshun section chief of security section of industrial and commercial bank, phone 13985328499 was suffered from gout 8 years, and uric acid level reaches 488 μ mol/L, the enlargement of right crus of diaphragm toe, pain.Take powder of the present invention, 12 days transference cures are not seen recurrence afterwards.
In sum, the Chinese powder medicine of treatment gout of the present invention is the specific drug of gout, is applicable to the patient with gout that all cause because of the uric acid height.
The specific embodiment
Embodiment gets Cortex Phellodendri 40g, Rhizoma Atractylodis 40g, Rhizoma Arisaematis 40g, Ramulus Cinnamomi 5g, Radix Clematidis 5g, Flos Carthami 5g, Rhizoma Et Radix Notopterygii 5g, Radix Stephaniae Tetrandrae 10g, Radix Angelicae Dahuricae 10g, Semen Persicae 10g, Radix Gentianae 20g, Rhizoma Chuanxiong 20g, Massa Medicata Fermentata preparata 20g.Above-mentioned medical material is mixed according to formula proportion, and common the grinding becomes the 230g powder, is the Chinese powder medicine of treatment gout.

Claims (3)

1. Chinese powder medicine for the treatment of gout is characterized in that this powder is made up of principal agent and accessory drugs, and wherein the medical material of principal agent is Cortex Phellodendri, Rhizoma Atractylodis, Rhizoma Arisaematis; The medical material of accessory drugs is Ramulus Cinnamomi, Radix Clematidis, Flos Carthami, Rhizoma Et Radix Notopterygii, Radix Stephaniae Tetrandrae, the Radix Angelicae Dahuricae, Semen Persicae, Radix Gentianae, Rhizoma Chuanxiong, wonderful Massa Medicata Fermentata; The quality proportioning of various medical materials is: Cortex Phellodendri 40: Rhizoma Atractylodis 40: Rhizoma Arisaematis 40: Ramulus Cinnamomi 5: Radix Clematidis 5: Flos Carthami 5: Rhizoma Et Radix Notopterygii 5: Radix Stephaniae Tetrandrae 10: the Radix Angelicae Dahuricae 10: Semen Persicae 10: Radix Gentianae 20: Rhizoma Chuanxiong 20: Massa Medicata Fermentata preparata 20.
2. Chinese powder medicine as claimed in claim 1 is characterized in that described Cortex Phellodendri will be with using after the wine parch; Rhizoma Arisaematis then will be with using after the Rhizoma Zingiberis Recens parch.
3. Chinese powder medicine as claimed in claim 1 is characterized in that this powder is that described medical material is mixed according to formula proportion, the powder that grinds to form jointly.
CN2010102622805A 2010-08-25 2010-08-25 Traditional Chinese medicinal powder for treating uarthritis Pending CN101940677A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010102622805A CN101940677A (en) 2010-08-25 2010-08-25 Traditional Chinese medicinal powder for treating uarthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010102622805A CN101940677A (en) 2010-08-25 2010-08-25 Traditional Chinese medicinal powder for treating uarthritis

Publications (1)

Publication Number Publication Date
CN101940677A true CN101940677A (en) 2011-01-12

Family

ID=43433007

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010102622805A Pending CN101940677A (en) 2010-08-25 2010-08-25 Traditional Chinese medicinal powder for treating uarthritis

Country Status (1)

Country Link
CN (1) CN101940677A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103393865A (en) * 2013-07-29 2013-11-20 肖变化 Medicament for treating gout and preparation method thereof
CN104940484A (en) * 2015-07-07 2015-09-30 王俊学 Traditional Chinese medicine for treating gout

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101642535A (en) * 2009-06-14 2010-02-10 李承平 Medicinal composition for treating gout

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101642535A (en) * 2009-06-14 2010-02-10 李承平 Medicinal composition for treating gout

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
(清)汪讱庵著辑: "《医方集解》", 31 December 1991 *
张永兰等: "上中下通用痛风方的临床应用", 《吉林中医药》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103393865A (en) * 2013-07-29 2013-11-20 肖变化 Medicament for treating gout and preparation method thereof
CN104940484A (en) * 2015-07-07 2015-09-30 王俊学 Traditional Chinese medicine for treating gout

Similar Documents

Publication Publication Date Title
CN102488869B (en) Traditional Chinese medicinal external-use liniment for muscle and bone ache
CN106421663A (en) Medicine composition for treating rheumatoid bone disease and preparation method thereof
CN104689173B (en) A kind of compound Chinese medicinal preparation for treating gout
CN105362491A (en) External-use medicine for treating cervical vertebra hyperosteogeny
CN105233145A (en) Musk medicine for dispelling wind
CN102302733B (en) Oral Chinese medicinal composition for treating ovarian cyst
CN105435172A (en) Ointment for treating chilblain
CN102526275B (en) Pharmaceutical for curing gout and preparation method thereof
CN104815286A (en) Traditional Chinese medicine prescription for treating prosopalgia
CN101940677A (en) Traditional Chinese medicinal powder for treating uarthritis
CN104587414A (en) Traditional Chinese medicinal composition for treating headache
CN104547747A (en) Fast-acting medicinal liquor for treating wind-cold-dampness arthralgia and application thereof
CN104096115A (en) Traditional Chinese medicine composition for treating acute gouty arthritis
CN103316228A (en) Scorpio unsting wine
CN101269194B (en) Medicament tincture for treating scobination type prurigo and preparation method thereof
CN103933408A (en) Traditional Chinese medicinal decoction for treating acute gouty arthritis
CN106389744A (en) Formula of traditional Chinese medicine for treating gout
CN105663850A (en) Traditional Chinese medicine composition for treating oral ulcer
CN105998738A (en) Traditional Chinese medicinal composition for treating night sweat
CN104623333A (en) Drug for treating facial paralysis
CN1686431A (en) External use bath liquid used for treating gout disease and its preparation method
CN102949534B (en) Traditional Chinese medicine for treating cervical spondylosis and preparation method thereof
CN102139022B (en) Medicament for treating lumbar intervertebral disc protrusion and rheumatism
CN103372170A (en) External traditional Chinese medicine for treating pyretic arthralgia, and preparation method thereof
CN101972335A (en) Chinese medicinal preparation for treating molluscum contagiosum

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110112